Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch [Seeking Alpha]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Keith Sullivan, President, CEO & Director, announced a leadership transition: "the Board has appointed Dan Reuvers as our next President and Chief Executive Officer of Neuronetics effective March 23. Dan is a proven leader with more than Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Growth was driven by strong capital shipments, increased treatment volume in Greenbrook clinics, addition of new referring providers, and momentum with therapies like SPRAVATO. The U.S. Attorney Office is investigating pre-acquisition billing practices; Neuronetics is fully cooperating but the outcome and implications are uncertain, thus posing a legal risk. 2026 revenue guidance is $160-$166 million (9% growth), clinic segment to grow double digits, NeuroStar business low-to-mid single digits, gross margin expected at 47-49%, operating cash flow positive expected for H
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Neuronetics (STIM) had its price target lowered by Canaccord Genuity Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.MarketBeat
- Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Neuronetics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Neuronetics (STIM) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Neuronetics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 3/17/26 - Beat
STIM
Analyst Actions
- 3/19/26 - Canaccord Genuity
STIM
Sec Filings
- 3/19/26 - Form 144
- 3/19/26 - Form 144
- 3/18/26 - Form 4
- STIM's page on the SEC website